Oramed Pharmaceuticals Inc. (TLV:ORMP)

Oramed Pharmaceuticals Revenue

Oramed Pharmaceuticals had revenue of $2.00M USD in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $2.00M, up 196.74% year-over-year.

• Revenue (ttm): $2.00M
• Revenue Growth: +196.74%
• P/S Ratio: 40.93
• Revenue / Employee: $500.00K
• Employees: 4
• Market Cap: 304.80M ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	1.34M	-1.36M	-50.43%
Dec 31, 2022	2.70M	-9.00K	-0.33%
Dec 31, 2021	2.71M	9.00K	0.33%
Aug 31, 2021	2.70M	-9.00K	-0.33%